Japan's New York Times reported that Japanese Prime Minister Shinzo Abe is pushing 'Abigan', a domestically developed drug, as a treatment for corona19, despite the potential for serious side effects.

Abigan is an antiviral drug developed by Toyama Chemical, a subsidiary of Fujifilm in Japan, to treat new influenza.

Experts believe that there is no clear evidence that it is effective in treating corona19 and that it has side effects that can lead to birth defects.

At the press conference on April 4, Prime Minister Abe himself said Abigan had side effects such as "thalidomide," an anti-morning drug.

Thalidomide is a drug that was banned due to side effects of birth defects in the 1950s and 1960s, and is considered to be the 'worst case of adverse drug reactions'.

Abigan has potential value in that it interferes with the reproduction of deadly viruses such as Ebola, but the evidence points to limited evidence that it can only cure diseases afflicted by humans, which has only been demonstrated in animal studies.

However, Prime Minister Abe is actively encouraging the use of Abigan as a remedy for Corona19 at G7 summits, including President Trump, as well as press conferences.

Prime Minister Abe has allocated a budget close to 160 billion won in our money by doubling Abigan's inventory, and in some countries offering Abigan for free and aggressively marketing.

The New York Times noted that while the Prime Minister Abe's aggressive recommendation for Abigan was unknown, he was close to the club, often playing golf and eating with President Fujifilm Shigetaka Komori.

However, Cabinet Secretary Yoshihide Suga stated that Abe's evaluation of Abigan's relationship with President Komori was "no relationship at all," and a spokesman for Fujifilm said that there was "no favor" by the government.

Prime Minister Abe's "affection" toward Abigan praises Trump's malaise treatment chloroquine-based hydroxychloroquine as a Corona19 treatment, but experts recall the opposition.

He said, "If political leaders support the right remedies to save lives, they can strengthen their political assets, gain international reputation, and benefit the company tremendously, but promoting the wrong drugs can be disastrous." .